myirislogo
21 December, 2014 12:18 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 304.25 0.73
Hindalco In 157.65 2.64
Infosys 2001.90 1.81
Icici Bank 355.40 2.95
Tata Stl 405.20 2.99
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Biocon Limited
Biocon Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532523NSE:BIOCONBloomberg:BIOS@INReuters:BION.BO
Market Lot: 1Face Value: 5ISIN Demat: INE376G01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
03-NOV-14 Biocon, a leading biotechnology company, and U.S. based CytoSorbents Corporations announced today that they have expanded the scope of their strategic partnership for CytoSorbents' CytoSorb cytokine reduction therapy to treat patients experiencing severe whole body inflammation, often called a Systemic Inflammatory Response Syndrome (SIRS). 22-OCT-14 During the quarter, the profit of the company declined 0.10% to Rs 1,020.50 million ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
FIIs cut stake in Biocon by almost 1 percentage point  -IRIS 08-Oct-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Sep-2014(6)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 10733.8020980.7018374.80
Other Income1264.10605.80514.70
Total Income11997.9021586.5018889.50
Cost of goods sold8863.7017292.4015323.10
OPBDIT3134.204294.103566.40
PAT2561.503298.502757.00
Gross Block---
Equity capital1000.001000.001000.00
EPS (Rs.)-16.5314.08
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-16.00 - 30.0914.78 - 22.83
Debt / Equity (x)---
Operating margin (% of OI)26.119.918.9
Net margin (% of OI)21.315.314.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
20th KM, Hosur Road
Electronics City Post Office
Bangalore
Karnataka-560 100
PHONE
(080) 2808 2808/ 3037
FAX
(080) 2852 3423
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer